The Latest Breaking News on Pharma

Authorities plan to acquire enough Covid-19 vaccines next year initially for 18 million people in high-risk groups, with the number of shots each person will need subject to World Health Organization (WHO) guidance.

Cannabis-based drugs like CBD and THC show surprising potential for defeating antibiotic-resistant germs

RSV can lead to severe lung issues in very young children including bronchiolitis and pneumonia

PHILADELPHIA -- Philadelphia’s most prominent immunization expert isn’t planning to get the latest COVID-19 booster shot, and doesn’t think most others need to either.

A surge in cases is indicating a new wave has started in the UK

Fainting and fatigue may signal onset of variant, experts say

Booster vaccinations are being offered to everyone in England over the age of 50

The Department of Health says fifth doses of a COVID-19 vaccine are not currently being recommended for most people.

Two Dutch nationals, an Englishman and nine companies have been targeted for sanctions by the U.S. government for allegedly operating an illegal fentanyl ring that generated millions of dollars in virtual currency

Respiratory Syncytial Virus is the leading cause of infant hospital admissions in the UK.

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…